eli lilly glp-1 pipeline Novo Nordisk Vs Lilly: Novo A Clear Winner (NYSE:NVO) GLP-1 Pipeline Update: November 2024

Adjusting Concomitant Diabetes Medications Safely When initiating GLP-1 therapy, clinicians should evaluate the patients entire regimen

[PubMed] [Google Scholar] 141.Rudd J.A., Chan S.W., Ngan M.P., Tu L., Lu Z., Giuliano C., Lovati E., Pietra C

If bruising becomes bothersome, discuss switching to oral semaglutide ($289/month) or other PlexusDx formulations with your care team, as each option suits different patient preferences and tolerances

Tirzepatide-related fatigue usually resolves as your body adjusts to the new dose

Additionally, GLP-1 drugs like tirzepatide reduce appetite, slow digestion, and may cause digestive side effects

A decrease in the antioxidant capacity of the brain may have functional consequences through cell damage, chronic inflammation, protein, and DNA damage